Blueprint Medicines Corporation Common Stock. Replay the stock market charts of BPMC day by day, back to 2003. Open long and short positions without spending any money. Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. Its drug candidates include avapritinib, BLU 554, BLU-782 and BLU-667.
